Correction of serum potassium with sodium zirconium cyclosilicate in Japanese patients with hyperkalemia: a randomized, dose–response, phase 2/3 study

BACKGROUND: Sodium zirconium cyclosilicate (SZC) is an oral potassium binder approved to treat hyperkalemia in adults in a number of countries, including Japan. METHODS: This phase 2/3, randomized, double-blind, placebo-controlled, dose–response study (ClinicalTrials.gov: NCT03127644) was designed t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Exp Nephrol
Autors principals: Kashihara, Naoki, Nishio, Toshiki, Osonoi, Takeshi, Saka, Yosuke, Imasawa, Toshiyuki, Ohtake, Takayasu, Mizuno, Hiroshi, Shibagaki, Yugo, Kim, Hyosung, Yajima, Toshitaka, Sarai, Nobuaki
Format: Artigo
Idioma:Inglês
Publicat: Springer Singapore 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7599176/
https://ncbi.nlm.nih.gov/pubmed/32779057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10157-020-01937-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars